Guiding Principles

At its launch event in 2023, the Consortium established four key principles to guide and implement its Action Plan. By continuing to grow the Consortium and adding non-traditional participants, the Consortium aims to extend the reach and momentum to meet cervical cancer elimination goals.

Where historically policies, programs, and people have worked independently across the three pillars, the Global HPV Consortium will spur a paradigm shift towards a unified and trans-disciplinary alliance of agendas and changemakers.

The Consortium will look to implement Integration in two ways:

  1. Integration across primary and secondary prevention by activating a unified vision and coordination across ministries and funding streams at the policy level and supporting holistic service delivery modalities at the program level.
  2. Integration into existing health services, leveraging existing infrastructure and workforce capacity

Equitable access to vaccines, screening and treatment services requires creative solutions to barriers such as gender, ethnicity, and socioeconomic status and a keen focus on groups who continue to be left behind. Marginalized and difficult-to-reach populations include indigenous, tribal, mobile or migrant populations; out-of-school girls; ethnic and religious minorities; people living with disabilities.

Women living with HIV are 6 times more likely to be diagnosed with cervical cancer in their lifetime compared to women without HIV. These women are more likely to acquire HPV infection, less likely to clear infection, and more likely to experience recurrence after treatment of precancerous lesions. Communities such as transgender and non-binary populations are left behind under current policies. For example, current SAGE technical guidance includes provisions for boys and girls but does not include the transgender community in their recommendations.

The Consortium will spotlight these disparities to increase awareness, highlight opportunities, and augment access through locally developed solutions.

Embracing the distinctions both between and within countries and communities requires movement away from a ‘one-size-fits-all’ approach and towards policies and programs informed from the national, sub-national, and local levels.

Between countries:

  • Health systems are unique and their functioning is determined by distinct infrastructure, resources, incentives, and measures of success.
  • Cross-country learning and exchange of successes and solutions will expand potential advances.

Within countries:

  • Engaging with ministries and sub-national leaders and implementers will better support locally designed solutions and increase buy-in and community trust.
  • Distinct communities and groups, such as those highlighted in the Equity section, require unique approaches that cannot be homogenized if service delivery is to be aligned within community norms.
  • Facilitating feedback loops from the local to national level can promote the development of policies and programs that are designed to meet the needs of the communities they aim to serve.

The Consortium will continue to stress that those closest to the challenge must be part of co-designing solutions.

Sustaining coverage rates of primary and secondary prevention services well beyond the period of introduction requires action and attention across policy, financing, service delivery, the workforce, and the community.

Without a global-level funding stream to provide countries with support for integration of cervical cancer prevention, it often falls to domestic budgets to execute this holistic approach. Thus, countries must be supported in the design and development of domestic financing plans that can be maintained beyond the period of introduction to ensure interventions remain robust and effective.

Achieving sustained action and investment will include:

  • Strong political prioritization at the national level
  • Sufficient and smart domestic financing mechanisms for holistic cervical cancer elimination strategies
  • Stable supply of vaccines and secondary prevention products
  • Cost effective, community-owned, and integrated service delivery models
  • A skilled and motivated workforce
  • Acceptance and demand for preventive services among target communities

Action Plan

The Consortium’s Action Plan seeks to respond to the needs and challenges that countries and communities face to make cervical cancer history. The action plan will encompass four key areas:

Advocacy and Thought Leadership

  • Unify global stakeholders from the private, public, non-profit and civil society sectors across the three pillars of vaccination, screening, and treatment to accelerate action towards cervical cancer elimination goals.
  • Foster collaboration among partners to enhance synergistic action and impact.
  • Support strategic communications across Consortium-owned and partner
    platforms to galvanize action, foster thought-leadership, and build an
    engaged community.
  • Cultivate an active network of strong champions (cancer survivors, youth
    advocates, women and transgender influencers, and global leaders) to raise
    awareness and win political commitment at the national and local levels.
  • Advocate for integrated and pro-equity approaches to HPV and cervical
    cancer-related policies, funding, and programming by global institutions
    and country governments.
  • Leverage major global health and policy events to amplify advocacy,
    partnerships, and opportunities for the Consortium.

Knowledge Management and Exchange

  • Create a hub that aggregates evidence, data, case studies, and best practices on HPV prevention and cervical cancer elimination.
  • Develop and sustain a ‘learning collective’ among Consortium partners and participants to enable multi-directional dialogue and exchange of ideas, learnings, and opportunities.
  • Share ways to improve integration of primary and secondary prevention services, including holistic policymaking and financing, health systems strengthening, and workforce capacity building.
  • Disseminate best practices for introduction and scale-up across primary and secondary prevention.
  • Harness evidence to advocate for groups at greater risk for HPV and cervical cancer, including women living with HIV, transgender individuals and out-of-school adolescents.
  • Amplify the role and voices of adolescents, youth, and women.
  • Strengthen data collection and analysis on disease burden, mortality, and the coverage of vaccination, screening, and treatment services.
  • Promote access to advancements and innovations across the value chain of prevention, including delivery models, self-sampling, multi-pathogen diagnostics platforms, early treatment options, cold chain innovation, and data management.

Convening of Key Stakeholders

  • Gather global and regional stakeholders to promote cross-country and transdisciplinary exchange and learning for HPV prevention and cervical cancer elimination.
  • Organize country-level meetings at a national and sub-national level to initiate feedback loops and build accountability among stakeholders.
  • Hold customized workshops among government representatives, Consortium partners, and key opinion leaders to disseminate information and facilitate cross-learning.

Country-Based Support

  • Mobilize political will for the prevention and elimination agenda through strategic outreach and engagement with health ministers, First Ladies, multilateral institutions, donors, key influencers, and civil society organizations.
  • Support national and sub-national governments in developing and implementing comprehensive and sustainable policies and plans to prevent HPV and eliminate cervical cancer.
  • Build contextualized investment cases for cervical cancer elimination by collating country-specific evidence, data, and budgeting tools.
  • Support countries in securing sufficient and sustainable financing.
  • Conduct social and behavioral research to understand and lift barriers to
    vaccination, screening, and treatment services.
  • Spur, share, and support locally tailored, community-driven, service delivery models for vaccination, screening, and treatment.

Recommended for you

JOIN THE CONSORTIUM

Be a part of the Consortium’s growing public and private sector collaboration